News

Coronavirus cases are spiking across the country, and local and state governments are trying to curb the spread.  Here’s a synopsis of pandemic-created changes to review as we head into winter and the holiday season. In most cities, expect indoor dining to no longer be an option — it’s already happened in Philadelphia and St.
0 Comments
After many years of good management of their high blood pressure, Americans are letting that control slip: the number of Americans with uncontrolled blood pressure rates has been rising. And while this trend has been creeping up since 2015, Covid-19, as with most things today, seems to have left its mark.   These increasing numbers aren’t
0 Comments
Combination treatment with the investigational, selective KIT inhibitor PLX9486 plus sunitinib (Sutent) was safe and active in patients with relapsed or refractory gastrointestinal stromal tumors (GIST), a small phase I/II study found. Among 18 patients treated with the combination, one achieved a complete response, two had partial responses, and another had an unconfirmed partial response,
0 Comments
The full 5-year results of a long-term extension study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5,400 patient-years of prospective follow-up, Diamont Thaçi, MD, PhD, reported at the virtual annual congress of the European Academy of Dermatology and Venereology. For example, 89% of
0 Comments
Many of us are frittering away time on Facebook or Twitter as we hunker down at home during the pandemic. But there’s a potential upside to all this social media engagement: It lets public health officials know how people feel about Covid-19 restrictions and can be used to encourage compliance. Australian researchers found that social
0 Comments
A novel algorithm-based disease management program, led by pharmacists and nonlicensed navigators, optimized cholesterol and blood pressure levels in high-risk patients, according to an interim report from the first 5000 patients. Mean low-density lipoprotein cholesterol (LDL-C) levels fell from 125 mg/dL to 73 mg/dL among those who finished active treatment titration and from 133 mg/dL
0 Comments
Treatment with an investigational albumin-bound mTOR inhibitor showed long-lasting responses in patients with advanced malignant perivascular epithelioid cell tumors (PEComa), extended follow-up from the single-arm AMPECT study showed. On independent review, the overall response rate (ORR) with nab-sirolimus in 31 malignant PEComa patients was 39% (95% CI 22-58), including one complete response, meeting the primary
0 Comments
The interventional cardiology community is mourning the loss of Prof Anthony “Tony” Gershlick, MBBS, who died November 20 of COVID-19. He was 69. Gershlick was a “talented, dedicated and much loved colleague,” reads a statement issued by the University of Leicester, where he was affiliated for more than three decades. Gershlick, a consultant cardiologist at
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Scientists involved in oversight of the Operation Warp Speed COVID-19 vaccine trials are tempering excitement about efficacy, noting that the studies haven’t shown yet whether the products can prevent transmission of the SARS-CoV-2 virus. “We don’t know if people can become
0 Comments
Because of the stalled economy, especially reductions in air and auto traffic, US greenhouse gas emissions are expected to drop 9.2% in 2020, their lowest level in three decades, according to a study by BloombergNEF. Earlier studies have shown reductions in particulate matter, both here and abroad. That remarkable 9.2% drop is partially offset by
0 Comments
The United States Medical Licensing Examination (USMLE) Step 2 Clinical Skills (CS) assessment is switching to a remote virtual format, according to an announcement detailed in a podcast on Thursday. The all-day exam, which traditionally requires test takers to have physical contact with standardized patients, has been suspended during the pandemic for safety reasons. Thursday’s
0 Comments
Eight months after it began developing its Covid-19 vaccine, Pfizer formally filed for emergency use authorization from the US Food and Drug Administration on Friday. https://www.npr.org/2020/11/20/937026003/pfizer-asks-fda-to-approve-its-covid-19-vaccine-for-emergency-use “Filing for Emergency Use Authorization in the U.S. is a critical step in making our vaccine candidate available to the global population as quickly as possible,” BioNTech CEO Ugur
0 Comments
We may have a new vaccine approved by the holidays. What we might not have is a clear picture of how to distribute it, according to President-elect Joe Biden’s transition team. Despite 11.5 million infected individuals and more than 250,000 US deaths from Covid-19 as of this morning, the Trump administration still refuses to allow
0 Comments
The administrative burden of medicine significantly contributes to physician and clinician burnout, electronic health systems, or EHR system design and workflow as a lead culprit. As such, recent EHR technology innovation tactics have focused on automating components of data entry and documentation. These technology innovations could significantly reduce the amount of time we spend crafting
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) today issued an emergency use authorization (EUA) for the janus kinase inhibitor baricitinib (Olumiant, Eli Lilly) in combination with remdesivir (Veklury, Gilead) for treating hospitalized adults and children at least 2 years old with suspected
0 Comments
For sports lovers, the year 2020 is one to forget. Seasons have withstood many disruptions, only to be brought back in unfamiliar formats with few, if any, fans in the stands.  It’s also been a year to witness how well, or just the opposite, sports leagues have handled the pandemic. For some leagues, thanks to
0 Comments
Health literacy is a global problem. Nine out of 10 adults have trouble applying the health information they see in the media or get from healthcare facilities to their own lives.  Defined as how well a person can find and understand the information they need, health literacy affects every decision we make about our health,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Public health — the science of protecting and improving the health of a population — includes everything from setting pollution limits to urging women to get mammograms. It’s investigating salmonella outbreaks, tracking Lyme disease, defining drunk driving, fighting climate change, tackling
0 Comments
Middle-age adults who took low-dose vitamin D supplements for 5 years had a small but statistically lower risk of developing metastatic or fatal cancer, a new analysis of a randomized trial showed. The absolute difference — 1.7% with vitamin D versus 2.1% without — represented a 17% reduction in relative risk (P=0.04). Normal-weight individuals derived
0 Comments